|
Volume 272, Number 16,
Issue of April 18, 1997
pp. 10975-10980
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
In Vivo Ultraviolet and Dimethyl Sulfate Footprinting
of the 5 Region of the Expressed and Silent Xist
Alleles*
(Received for publication, December 6, 1996, and in revised form, February 14, 1997)
Jun-ichiro
Komura
,
Steven A.
Sheardown
§,
Neil
Brockdorff
§,
Judith
Singer-Sam
¶ and
Arthur D.
Riggs
From the Biology Department, Beckman Research
Institute of the City of Hope, Duarte, California 91010 and the
§ Section of Comparative Biology, Medical Research Council
Clinical Sciences Centre, Royal Postgraduate Medical School,
Hammersmith Hospital, DuCane Road,
London W12 ONN, United Kingdom
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
The Xist (X inactive specific
transcript) gene plays an essential role in X chromosome inactivation.
To elucidate the mechanisms controlling Xist expression and
X inactivation, we examined in vivo DNA-protein
interactions in the Xist promoter region in a female mouse
cell line (BMSL2), which has distinguishable Xist alleles.
In vivo footprinting was accomplished by treatment of cells
with dimethyl sulfate or ultraviolet light, followed by ligation-mediated polymerase chain reaction of purified DNA. The expressed allele on the inactive X chromosome and the silent allele on
the active X chromosome were separated by the use of a restriction fragment length polymorphism prior to ligation-mediated polymerase chain reaction. The chromatin structure of the Xist
promoter was found to be consistent with the activity state of the
Xist gene. The silent allele (on the active X chromosome)
showed no footprints, while the expressed allele (on the inactive X
chromosome) showed footprints at a consensus sequence for a CCAAT box,
two weak Sp1 sites, and a weak TATA box.
INTRODUCTION
Early in embryogenesis, X chromosome inactivation
(XCI)1 causes the heterochromatinization
and genetic silencing of one of the two X chromosomes in female
mammalian cells (see Refs. 1 and 2). The details of the establishment
and maintenance of XCI are not yet known, but recent work has indicated
that an X-linked gene, Xist (X inactive specific
transcript), plays a critical role at least in the establishment stage
(reviewed in Refs. 3 and 4). The Xist gene (XIST
in humans) is expressed only from the inactive X chromosome (Xi) and
thus only in female somatic cells. Xist codes for a large
RNA that is preferentially localized in the nucleus and has no
conserved open reading frame. The gene maps to the X inactivation
center, which includes the X-controlling element, a cis-acting locus
that controls the likelihood of inactivation of a given X chromosome.
Recent evidence suggests that the X-controlling element locus (5), as
well as other potential key elements of XCI (6, 7), are separate from
Xist. Although the X inactivation center region including
Xist is apparently not necessary for the maintenance of XCI,
at least in cultured cells (8), other recent evidence suggests a
possible role at several stages of XCI. The level of Xist
RNA increases early in embryogenesis just prior to the time of XCI,
which is indicative of a role in establishment (9). In addition,
deletion of one Xist allele by gene targeting in female
embryonic stem cells has provided strong evidence that Xist
is necessary in cis for XCI to occur both in vitro and
in vivo (6), although it apparently does not affect
mechanisms for counting or X chromosome selection (10). Furthermore,
cytological studies showing localization of Xist RNA to Xi
(10, 11) suggest some role in maintaining the structure of the inactive
X, despite the relatively low levels of Xist transcripts
(12). Lee et al. (13) have recently found that in ES cells
sequences contained within a 450-kb YAC including the Xist
gene are sufficient to induce inactivation when integrated into
autosomes in multiple copies. In addition to the Xist locus,
the YAC includes a GC-rich island 15 kb 3 to the Xist gene
that is hypermethylated on the active X chromosome, to an extent that
varies with different X-controlling element loci (7). Taken together,
these studies suggest that protein-DNA and protein-protein interactions
at the Xist promoter are likely to be important for
understanding the establishment of XCI. In addition to studies
indicating differential DNA methylation in the Xist 5
region (14), there has so far been one published report on DNA-protein
interactions at the promoter (15). In that report, in vitro
gel mobility shift assays and reporter gene assays were used to
characterize several functional elements, including a potential
TATA-binding protein element 25 to 30 base pairs from the
transcription start site and a second element just upstream of this
site.
Here we report results of an in vivo footprinting study of
the Xist promoter region, in which we separately analyzed
the expressed and silent Xist alleles after in
vivo treatment of the mouse female cell line, BMSL2 (16). Intact
cells were treated with dimethyl sulfate (DMS) or UV, and then the DNA
was analyzed by use of ligation-mediated PCR (LMPCR). We find evidence
for several specific protein-DNA interactions on the expressed
Xist allele, but none on the silent allele.
EXPERIMENTAL PROCEDURES
Culture and Treatment of Cells
BMSL2 cells (HOBMSL2 cells)
(16) are derived from F1 female liver cells of the cross
C57BL/6-Hprta Pgk-1a
(strain AT29) × congenic strain
Hprtb-m3Pgk-1b (strain
BM3). The cells were maintained in Dulbecco's modified Eagle's medium
containing 4.5 g/liter glucose, supplemented with 1 × nonessential amino acids and 10% fetal bovine serum. They were grown
as monolayers to about 70% confluency and then were used for DMS
treatment or UV irradiation. After treatment of the cells with 0.1%
DMS (Aldrich) in serum-free medium at room temperature for 5 min, they
were washed twice with serum-free medium, washed once with
phosphate-buffered saline, and then were lysed. UV irradiation was
performed using a Stratalinker 2400 UV cross-linker (Stratagene). The
cells were washed once with phosphate-buffered saline, irradiated with
1000 J/m2 UV (254 nm), and lysed immediately.
Isolation and in Vitro Treatment of DNA
The cells were
lysed by the direct addition of 10 mM Tris (pH 7.5), 10 mM EDTA, 50 mM NaCl, 0.5% SDS, and 0.3-0.5
mg/ml proteinase K. The lysates were incubated at 37 °C overnight.
In the case of DMS treatment, the incubation time was shortened to
3 h to minimize cutting of the DNA at modified residues at this
incubation temperature. After the addition of NaCl to a final
concentration of 290 mM, the lysates were extracted once
with phenol and once with chloroform. Nucleic acids were precipitated
with an equal volume of 2-propanol, resuspended in 10 mM
Tris (pH 7.5), 1 mM EDTA, and 5 µg/ml DNase-free RNase
(Boehringer Mannheim), and incubated at room temperature overnight.
After phenol extraction and chloroform extraction, DNA was precipitated
with 2-propanol.
As a control, DNA extracted from untreated cells was treated in
vitro with DMS or UV. In vitro DMS treatment was
performed essentially as described by Maxam and Gilbert (17). DNA (100 µg) was treated with 0.2 µl of DMS in a volume of 202 µl at room temperature for 2 min. In vitro UV treatment was performed
by exposing 50-µl droplets containing 0.1 mg/ml DNA, 10 mM Tris (pH 7.5), and 1 mM EDTA to 1000 J/m2 UV.
Separation of Expressed and Silent Alleles
DNA of each
sample (40 µg) was digested with restriction endonucleases
HpaI, PvuII, and XbaI (200 units each)
at 37 °C for 5 h. The resulting restriction fragments were
separated by electrophoresis through a 0.8% agarose gel in 50 mM TBE buffer containing 2 µg/ml ethidium bromide. To
minimize photodamage, DNA was visualized by brief use of a long
wavelength ultraviolet transilluminator. Slits were cut in the gel
above and below the regions of interest, and the desired DNA fragments
(1.0-1.8 kb for Xi; 2.3-4.4 kb for active X chromosomes) were
collected by electrophoresis onto NA45 DEAE-cellulose membranes
(Schleicher and Schuell) (18). The fragments were eluted by incubating
the membrane three times for 30 min in 10 mM Tris (pH 7.5),
1 mM EDTA, and 2 M NaCl at 37 °C.
After phenol-chloroform extraction and 2-propanol precipitation,
samples (3 µg) were treated with piperidine to induce cleavage at the
sites of methylguanines or (6-4) photoproducts, or were incubated first
with T4 endonuclease V and then with photolyase to induce cleavage at
the sites of cyclobutane pyrimidine dimers, both as described by
Tornaletti and Pfeifer (19).
LMPCR
LMPCR was done essentially as described (19-21),
except that Vent (exo ) DNA polymerase (exo ;
New England Biolabs Inc.) was used in the first strand synthesis as
well as in the PCR step of LMPCR, and a post-PCR booster step was done
using AmpliTaq DNA polymerase (Perkin-Elmer). Six primers were used:
A1, GATATATTGAAATTTTGCATAGACA; A2, TTTTGCATAGACAGGTGTGTGACCTAATGT; A3,
CATTATTTAATGTTTATGTGGAAGTTCTACA; B1, CCATAAGGCTTGGTGGTAGG; B2,
CTTGGTGGTAGGGGAACTAAAAATGTTC; B3, AAAAATGTTCCCCCAAAGCTCCTTAG. The A
primers (upstream primers) were used to analyze the lower strand of the
Xist promoter. The B primers (downstream primers) were for
the analysis of the upper strand.
Cleaved DNA (0.3 µg) in 28 µl of first strand mix was denatured at
95 °C for 5 min and annealed for 20 min at 47 °C (with primer A1)
or at 51 °C (with B1). After the addition of 1.2 units of
exo (diluted to 2 µl) on ice, each sample was incubated
at the annealing temperature for 3 min and then at 72 °C for 2 min.
This reaction mixture (30 µl) contained 20 nM primer A1
or B1, 250 µM each dNTP, 5 mM Tris (pH 7.5),
0.5 mM EDTA, and 5 mM MgSO4 in
addition to 1 × ThermoPol Buffer (New England Biolabs Inc.).
After the addition of 40 µl of ligation solution (48 mM
Tris (pH 7.5), 19 mM MgCl2, 19 mM
dithiothreitol, 1.9 mM ATP, 48 µg/ml bovine serum
albumin, and 4.5 units (Weiss) of T4 DNA ligase) and 5 µl of 20 µM double-stranded linker in 250 mM Tris (pH
7.7) on ice, the mixture was incubated at 17 °C overnight. DNA was
precipitated by addition of 20 µl of 10 M ammonium
acetate, 2 µl of 0.5 M EDTA, 1.5 µl of 20 mg/ml glycogen, and 250 µl of ethanol. The precipitate was dissolved in 50 µl of water. After the addition of 50 µl of amplification mixture
consisting of 2 × ThermoPol Buffer, 8 mM
MgSO4, 0.5 mM each dNTP, 0.4 µM
primer A2 or B2, 0.4 µM linker primer, and 4 units of
exo , the sample was subjected to PCR using 23 cycles of 1 min at 95 °C (4 min at 95 °C for the first cycle), 2 min at
61 °C (with primer A1) or 59 °C (with B2), and 1 min at 72 °C.
After thermal cycling, AmpliTaq DNA polymerase (1 unit) was added, and
the sample was further incubated at 72 °C for 8 min prior to
phenol-chloroform extraction and ethanol precipitation.
Following published procedures (20, 21), the PCR-amplified fragments
were resolved by electrophoresis through a denaturing polyacrylamide
gel (8%), transferred to a nylon membrane by electroblotting, and
visualized by autoradiography after hybridization with a
single-stranded probe. The probe was made as described (22) from the
plasmid pGPT2 (14), consisting of the vector pBluescript II KS(+)
(Stratagene) and a 4.4-kb EcoRI insert that includes the 5
region of the Xist gene (see Fig. 1). After
HaeIII digestion, pGPT2 (50 ng) was mixed with 5 units of
Taq polymerase, GeneAmp 1 × PCR buffer (Perkin-Elmer), 0.5 µM primer A3 or B3, 0.67 µM
[ -32P]dCTP (3000 Ci/mmol), and 20 µM
each of dATP, dGTP, and dTTP in a volume of 50 µl. Repeated run-off
synthesis was performed with 30 cycles of 1 min at 94 °C (3 min at
94 °C for the first cycle) and 2 min at 52 °C (with primer A3) or
at 58 °C (with B3) and 2 min at 72 °C. The theoretical length of
the resulting single-stranded probes was 202 and 150 bases for
synthesis directed by primers A3 and B3, respectively. After visual
inspection of the autoradiogram, band ratios were measured by use of a
PhosphorImager (Molecular Dynamics, Inc.). Only regions showing at
least 50% differences between the in vivo sample and the
purified DNA control were considered to be footprints.
Fig. 1.
Restriction map of the 5 region of the mouse
Xist gene. The major transcription site, the A and B
primer sets used for LMPCR, and the probe used for Southern blot
hybridization are indicated. The PvuII site (*) is
polymorphic; only the expressed AT29 allele has the site. H,
restriction endonuclease HhaI.
[View Larger Version of this Image (8K GIF file)]
RESULTS
The mouse cell line BMSL2 is an established line derived from the
liver of female F1 hybrids with an active X chromosome
containing the Hprtb-m3 mutation (derived from
strain BM3) and an Xi carrying the Pgk-1a and
Hprta alleles (derived from strain AT29). The
cells contain normal steady-state levels of Xist
RNA.2 Sequence analysis after reverse
transcriptase PCR has shown that Xist RNA is transcribed
only from the AT29 X chromosome (16), whereas Pgk-1 RNA is
transcribed only from the BM3 X
chromosome.3 Because only the AT29 allele
has an extra PvuII site near the transcription start site
(6) (see Fig. 1), the promoter region of the BM3 allele
of the Xist gene can be distinguished from that of the AT29
allele by Southern blotting (Fig. 2). When DNA from BMSL2 cells was digested with PvuII in addition to
HpaI and XbaI (Fig. 2, lane 2), a
1.5-kb fragment (the AT29 allele) and a 3.5-kb fragment (the BM3
allele) were detected. Fig. 2 also shows that the BM3 Xist
allele is methylated at all HhaI sites in the 5 region
(Fig. 1), unlike the AT29 allele. When the methylation-sensitive enzyme
HhaI was added (Fig. 2, lane 3), the AT29 allele
was further digested, whereas the BM3 allele remained intact. Since
previous studies (14) have established that the silent allele is
methylated in somatic cells whereas the expressed allele is
unmethylated, these results further confirm that the BM3 allele is
silent, whereas the AT29 allele is expressed. Treatment of BMSL2 cells
with DMS (Fig. 2, lanes 4 and 5) or with UV
(lanes 6 and 7) before DNA extraction did not
interfere with agarose gel separation, as expected because breakage of
the DNA phosphodiester bonds does not take place until subsequent
chemical or enzymatic cleavage (19, 23). After electrophoresis and
recovery of separated fragments, the DNA was treated with piperidine or
with T4 endonuclease V and photolyase. Piperidine cleaves DMS-treated
DNA predominantly at sites of methylated guanines and UV-irradiated DNA
predominantly at sites of (6-4) photoproducts. T4 endonuclease V
cleaves UV-irradiated DNA at the sites of cyclobutane pyrimidine
dimers, and photolyase renders fragment ends ligatable.
Fig. 2.
Southern blot analysis. DNA samples from
BMSL2 cells were digested with HpaI and XbaI
(lane 1), HpaI, XbaI, and
PvuII (lanes 2 and 4-7) or
HpaI, XbaI, PvuII, and HhaI
(lane 3) and electrophoresed (with a /HindIII
digest as a marker) through a 0.8% agarose gel in TBE. DNA was
extracted from cells that were untreated (lanes 1-3), were
treated with 0.1% DMS for 1 (lane 4) or 5 (lane
5) min, or were irradiated with UV at a dose of 500 (lane
6) or 1000 (lane 7) J/m2.
[View Larger Version of this Image (46K GIF file)]
The positions of cleavage were determined at single-nucleotide
resolution by LMPCR. To increase sensitivity, we used Vent (exo ) DNA polymerase both in the first strand synthesis
and in the PCR step, instead of Sequenase and Taq DNA
polymerase (20, 21) or Vent DNA polymerase (24, 25). When the amount of
input DNA was small, the exo enzyme gave more intense
signals (see Fig. 3), perhaps because of the lack of
both 3 5 and 5 3 exonuclease activities. This enzyme, however,
generates two kinds of DNA fragment ends, blunt ends and single-base 3
overhangs, sometimes producing strong doublet bands in the sequencing
ladder (Fig. 3, lanes 5 and 6). To solve this
problem, we added after the last cycle of PCR a final treatment with
Taq polymerase. This booster step efficiently converts ends
into single-base overhangs (Fig. 3, lanes 7 and 8).
Fig. 3.
Comparison of LMPCR procedures.
Different polymerases were used during first strand extension
(ext.) and during PCR as indicated. Seq,
Sequenase 2.0 (U. S. Biochemical Corp.); exo ,
Vent (exo ) DNA polymerase; Taq, AmpliTaq DNA
polymerase. The booster step with Taq (lanes 7 and 8) was added after PCR. DNA samples were UV-irradiated
(in vitro irradiation, lanes 1, 3,
5, and 7; in vivo irradiation,
lanes 2, 4, 6, and 8), and
then the expressed Xist allele was isolated by gel
electrophoresis and piperidine-cleaved at the sites of (6-4)
photoproducts. The procedure with exo is described in the
text. First strand extension with Sequenase and PCR with Taq
were performed essentially as described by Pfeifer and Riggs
(21).
[View Larger Version of this Image (64K GIF file)]
In vivo footprints in the 5 region of the Xist
gene were discerned by comparing the pattern of the sequencing ladder
of the in vivo treated DNA sample with that of in
vitro treated purified DNA. Fig. 4 shows the result
of in vivo DMS and UV footprinting of the lower strand of
the Xist 5 region from nucleotide 180 to +9 relative to
the major transcription start site. Regions reproducibly showing 50%
or more reduction (or enhancement) in band strength relative to that of
the control are considered to be footprints and are marked by
vertical bars. All of the footprints detected in this study
were on the expressed allele; no footprints were observed on the silent
allele. We found weak protection from DMS in the regions from 49 to
50 and from 65 to 73 (Fig. 4, lanes 7 and
8). These two regions bind the transcription factor Sp1 with
low affinity in vitro.4 There
was a dipyrimidine showing strong hyper-reactivity for the in
vivo formation of cyclobutane pyrimidine dimers at nucleotides 102 and 103 only on the expressed allele. This TT dipyrimidine is
in the sequence ATTGG, hence in a consensus CCAAT box. The enhancement
of the formation of photoproducts in vivo in the CCAAT box
has been reported for the human PGK1, c-JUN, and
PCNA genes (19, 23). We also find a hyper-reactive site for
the in vivo formation of (6-4) photoproducts in the sequence
TTT at nucleotides 26 to 28, despite the fact that TT dinucleotides
are not preferred substrates for the formation of this photoproduct
(26). It has been suggested that this region (TTAAAG, 30 to 25) can
be recognized by TATA-binding protein but may bind another protein with
higher affinity (15). Assuming an interaction with TATA-binding
protein, the unusual formation of (6-4) photoproducts at this
dinucleotide might be due to the severe bending of DNA caused by the
interaction of TATA-binding protein with the TATA box (27, 28).
Fig. 4.
In vivo footprinting analysis of the
lower strand of the Xist 5 region (primer set A).
Distribution of DMS-induced methylguanines and UV-induced photoproducts
(cyclobutane pyrimidine dimers and (6-4) photoproducts) along the
sequence from nucleotide 180 to +9 relative to the major
transcription start site is shown. Lanes labeled
S denote samples of the silent allele; E,
expressed allele. Lanes labeled DNA denote
purified DNA samples footprinted in vitro, and lanes
labeled Cells denote samples footprinted in vivo. Control Maxam-Gilbert sequencing reactions (G,
A+G, T+C, C) were performed with BMSL2
DNA that had not been gel-separated (containing both alleles). The
numbers on the left indicate nucleotide positions
from the transcription start site. Vertical bars indicate footprints. A sequence difference at position 89 between the silent
and expressed alleles is apparent in the DMS and dimer lanes, verifying complete electrophoretic separation of the two alleles. The silent allele has T, and the expressed allele has G.
[View Larger Version of this Image (65K GIF file)]
Fig. 5 shows the analysis of the upper strand. No DMS
footprints are apparent on this strand, but three regions show UV
photofootprints. The strongest footprint is seen at the CC dipyrimidine
at position 105 to 104, where an enhancement of (6-4) photoproducts
is found (Fig. 5, lanes 15 and 16). These
nucleotides are in a consensus CCAAT box and just opposite the hot spot
for cyclobutane dimer formation (see Figs. 4 and 6).
Protection from the formation of both (6-4) photoproducts and
cyclobutane dimers is seen at nucleotides 69 to 68.
Hyper-reactivity for cyclobutane dimer formation is also seen at
nucleotides 66 to 65. These two dipyrimidine sites are opposite one
of the DMS footprint regions on the lower strand. We also detected a
weak hyper-reactive site for cyclobutane dimer formation (TTC at
nucleotides 48 to 46) opposite to the other DMS footprint region on
the lower strand.
Fig. 5.
In vivo footprinting analysis of the
upper strand of the Xist 5 region (primer set B).
Lanes and symbols are identical to those in Fig.
4. At any given dipyrimidine site, the position of the (6-4)
photoproduct appears one nucleotide shorter than that of the
corresponding cyclobutane dimer because of the difference in cleavage
methods.
[View Larger Version of this Image (57K GIF file)]
Fig. 6.
Summary of DMS and UV footprinting
experiments on both strands of the 5 region of the expressed allele of
the Xist gene. Dots and brackets
denote guanines and dipyrimidines, respectively. The horizontal
arrow indicates the major transcription start site. Open
symbols represent the sites of decreased formation of products in vivo; solid symbols represent those of
increased formation in vivo; large symbols
indicate prominent changes; ovals, methylguanines; triangles, cyclobutane pyrimidine dimers;
rectangles, (6-4) photoproducts. The base pair at position
89 on the silent allele is (A-T) instead of (C-G) on the expressed
allele shown on the figure.
[View Larger Version of this Image (26K GIF file)]
The results of our footprinting experiments on both strands are
summarized in Fig. 6. Four regions with in vivo footprints were found, and all of them were on only the expressed allele. Three of
the footprints can be detected on both upper and lower strands.
DISCUSSION
The function(s) of the Xist gene is not yet clearly
understood, but several studies suggest that it is a key element
necessary for the establishment of X inactivation (6, 13, 29).
Establishment is likely to have several stages, four of which are (i)
counting of the X to autosome ratio; (ii) initiation of the
inactivation process if X/autosome = 1 or more; (iii) choosing
which X remains active; and (iv) the spreading of inactivation to cover
most genes on the X. Xist may not be necessary for the
maintenance of X inactivation, at least in cultured cells (8), but on
the other hand, Xist RNA is found in female tissues at all
ages and has been postulated to be involved in chromosome
architecture (10).
Correct Xist function during the establishment of X
inactivation requires at least one other element to be located in cis within 1-2 megabases of the Xist locus (30). An interesting region showing differential methylation correlated with different X-controlling element alleles has, in fact, been identified by Courtier
et al. (7) 15 kb downstream of Xist. Recently,
Lee et al. (13) obtained evidence for a
"counting/choosing" element located within 450 kb of
Xist and have speculated that this cis-acting regulatory
element could sense an X chromosome number and then function as an
enhancer of Xist expression. Considering a somewhat different question, Rastan (4) has speculated that the Xist gene is part of the mechanism that, after initiation of the X inactivation process, leads to the retention of one and only one active
X chromosome per diploid autosomal set. The activation triggered by
counting the X/autosome ratio is postulated to lead to the expression
or activation of a blocking factor that binds to one copy of the
Xist gene. In a subsequent step, all copies of the X
chromosome that are not "blocked" become inactivated. In its
simplest form, this model suggests that the silent Xist gene
(which is on the active X chromosome) could be kept silent by the
binding of a special "blocking" factor. Both of these models suggest the need for characterization of protein-nucleic acid interactions at the Xist promoter. Also, since the
Xist gene is expressed from the Xi, it is to be expected
that a transcription complex will be present on the Xist
promoter located on the Xi. But will this complex be present only in
heterochromatin, as is found for some genes in Drosophila
(31, 32)? For these reasons, in vitro and in vivo
studies of the Xist promoter region may give substantial
mechanistic insight.
The mouse Xist promoter region has been characterized in a
previous study (15). Reporter gene constructs containing various deletions or mutations in the promoter region were used to assay transcription after transfection. The results indicated that the major
promoter activity is contained in a region from 82 to +20 relative to
the transcription start site. Gel shift assays also were done, and
sites for protein binding were identified. In no case were differences
seen between male and female cells. However, in vitro DNA
binding studies do not necessarily give an accurate picture of in
vivo protein-DNA interactions, since the in vivo chromatin structure can not yet be mimicked in vitro. We
therefore sought to do an in vivo analysis of the
Xist promoter region, but this is not straightforward
because Xist is only expressed in female somatic cells, and
these have an equal mixture of expressed and silent alleles. To study
the nucleoprotein structure of the expressed allele and to compare it
with the silent allele, it was necessary to separately assay the two
alleles. To accomplish this we used a hybrid mouse cell line (BMSL2)
that has Xist alleles which are electrophoretically
separable because of a restriction fragment length polymorphism.
Isolation of DNA fragments after in vivo treatment, but
prior to LMPCR, permitted separate analysis of silent and expressed
alleles from the same nucleoplasm. Thus a picture of the minimally
perturbed true in vivo chromatin configuration should be
obtained by these studies.
DMS is the most commonly used agent for both in vitro and
in vivo footprinting. This alkylating agent is convenient to
use, but detects DNA-protein interactions mainly at guanine residues, and DMS reactivity is not at all affected by some protein contacts, for
example those found in nucleosomes (33, 34). So far UV photofootprinting (19) has been less commonly used for in
vivo footprinting. UV makes two major photoproducts at sites of
neighboring pyrimidines, cyclobutane dimers and (6-4) photoproducts.
Photoreactivity is affected by alterations in DNA conformation induced
by the presence of bound protein. Photodimer sites then can be
converted to strand breaks and assayed by LMPCR (35, 36).
Using the complementary methods of DMS footprinting and UV
footprinting, we examined both strands of the promoter region of the
mouse Xist gene (Fig. 6). This region is not very rich in guanines but does have numerous dipyrimidines (Fig. 6). We detected four regions with in vivo DMS or UV footprints in the 5
region of the expressed allele (Figs. 4, 5, 6): a canonical CCAAT box (nucleotides 105 to 102), two weak Sp1 sites ( 73 to 65 and 50
to 46), and a weak TATA box ( 28 to 26). The in vivo
footprints we observed are not dramatic (<8-fold difference in signal
intensity versus the in vitro control), which is
as one might expect for a gene expressed at relatively low level. The
in vivo footprints we detected are in sequences rather well
conserved between mouse and human and correspond to the location of
in vitro footprints4. We did not see any
in vivo footprints at the major transcription start site,
which contains a consensus sequence for an initiator element (37),
although an in vitro footprint has been
observed4. However, it should be noted that no in
vivo footprints have been found at the transcription start site of
human PGK1, a highly expressed X-linked gene that also has a
consensus initiator near the start site (38). There was a clear
photofootprint in the weak TATA box about 30 nucleotides upstream of
the major start site, but we found no footprint in the TATA consensus
sequence (nucleotides 129 to 123), which is located ~40
nucleotides upstream of a minor start site (nucleotide 82). Thus, the
Xist promoter seems to work in vivo as a promoter
with a weak TATA box as has been suggested (15) and perhaps as a weak
initiator element.
Although both the expressed allele and the silent allele of
Xist are in the same nucleus, and potentially exposed to the
same transcription factors, there is no evidence for the presence of any transcription factors or special blocking factors on the silent allele. This result is consistent with in vivo footprinting
results for other X-linked genes in that the silent allele has no
transcription factors in the promoter region (38, 39). For normal
X-linked genes, it is assumed that methylation and/or a somatically
heritable chromatin structure prevents access of transcription factors
to the silent allele. This same mechanism thus seems likely to apply to
the Xist promoter region. The silent allele in somatic cells is highly methylated, while the expressed allele is not methylated (14). This difference is likely to be involved in maintenance by
stabilizing alternate chromatin structure.
FOOTNOTES
*
This work was supported in part by National Institutes of
Health Grant GM50575 (to A. D. R.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.:
818-301-8241; Fax: 818-358-7703.
1
The abbreviations used are: XCI, X chromosome
inactivation; Xist, X inactive specific transcript; Xi,
inactive X chromosome; DMS, dimethyl sulfate; kb, kilobase pair(s);
LMPCR, ligation-mediated polymerase chain reaction.
2
C. Buzin and J. Singer-Sam, unpublished
observations.
3
J. M. LeBon and J. Singer-Sam, unpublished
observations.
4
S. A. Sheardown and N. Brockdorff, unpublished
observations.
ACKNOWLEDGEMENTS
We thank Drs. J. M. LeBon, S. Tommasi, R. Dammann, and G. P. Pfeifer for their kind help, A. Sancar for
photolyase, and S. Lloyd for T4 endonuclease V.
REFERENCES
-
Lyon, M. F.
(1961)
Nature
190,
372-373
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lyon, M. F.
(1993)
Trends Genet.
9,
123-128
[CrossRef][Medline]
[Order article via Infotrieve]
-
Singer-Sam, J., and Riggs, A. D.
(1993)
in
DNA Methylation: Molecular Biology and Biological Significance (Jost, J., and Saluz, H., eds), pp. 358-384, Birkhauser Verlag, Berlin
-
Rastan, S.
(1994)
Curr. Opin. Genet. & Dev.
4,
292-297
[CrossRef][Medline]
[Order article via Infotrieve]
-
Simmler, M. C., Cattanach, B. M., Rasberry, C., Rougeulle, C., and Avner, P.
(1993)
Mamm. Genome
4,
523-30
[CrossRef][Medline]
[Order article via Infotrieve]
-
Penny, G. D., Kay, G. F., Sheardown, S. A., Rastan, S., and Brockdorff, N.
(1996)
Nature
379,
131-137
[CrossRef][Medline]
[Order article via Infotrieve]
-
Courtier, B., Heard, E., and Avner, P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
3531-3535
[Abstract/Free Full Text]
-
Brown, C. J., and Willard, H. F.
(1994)
Nature
368,
154-156
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kay, G. F., Penny, G. D., Patel, D., Ashworth, A., Brockdorff, N., and Rastan, S.
(1993)
Cell
72,
171-182
[CrossRef][Medline]
[Order article via Infotrieve]
-
Clemson, C. M., McNeil, J. A., Willard, H. F., and Lawrence, J. B.
(1996)
J. Cell Biol.
132,
259-275
[Abstract/Free Full Text]
-
Panning, B., and Jaenisch, R.
(1996)
Genes Dev.
10,
1991-2002
[Abstract/Free Full Text]
-
Buzin, C. H., Mann, J. R., and Singer-Sam, J.
(1994)
Development
120,
3529-3536
[Abstract]
-
Lee, J. T., Strauss, W. M., Dausman, J. A., and Jaenisch, R.
(1996)
Cell
86,
83-94
[CrossRef][Medline]
[Order article via Infotrieve]
-
Norris, D. P., Patel, D., Kay, G. F., Penny, G. D., Brockdorff, N., Sheardown, S. A., and Rastan, S.
(1994)
Cell
77,
41-51
[CrossRef][Medline]
[Order article via Infotrieve]
-
Pillet, N., Bonny, C., and Schorderet, D. F.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
12515-12519
[Abstract/Free Full Text]
-
Park, J. G., and Chapman, V. M.
(1994)
Mol. Cell. Biol.
14,
7975-7983
[Abstract/Free Full Text]
-
Maxam, A. M., and Gilbert, W.
(1980)
Methods Enzymol.
65,
499-560
[Medline]
[Order article via Infotrieve]
-
Sambrook, J., Fritsch, E. F., and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
-
Tornaletti, S., and Pfeifer, G. P.
(1995)
J. Mol. Biol.
249,
714-728
[CrossRef][Medline]
[Order article via Infotrieve]
-
Pfiefer, G. P., Singer-Sam, J., and Riggs, A. D.
(1993)
Methods Enzymol.
225,
567-583
[Medline]
[Order article via Infotrieve]
-
Pfeifer, G. P., and Riggs, A. D.
(1993)
Methods Mol. Biol.
16,
153-168
-
Tommasi, S., LeBon, J. M., Riggs, A. D., and Singer-Sam, J.
(1993)
Somat. Cell Mol. Genet.
19,
529-541
[CrossRef][Medline]
[Order article via Infotrieve]
-
Pfeifer, G. P., Drouin, R., Riggs, A. D., and Holmquist, G. P.
(1992)
Mol. Cell. Biol.
12,
1798-1804
[Abstract/Free Full Text]
-
Garrity, P. A., and Wold, B. J.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
1021-1025
[Abstract/Free Full Text]
-
Hornstra, I. K., and Yang, T. P.
(1994)
Mol. Cell. Biol.
14,
1419-30
[Abstract/Free Full Text]
-
Brash, D. E., Seetharam, S., Kraemer, K. H., Seidman, M. M., and Bredberg, A.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
3782-3786
[Abstract/Free Full Text]
-
Kim, J. L., Nikolov, D. B., and Burley, S. K.
(1993)
Nature
365,
520-527
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kim, Y., Geiger, J. H., Hahn, S., and Sigler, P. B.
(1993)
Nature
365,
512-520
[CrossRef][Medline]
[Order article via Infotrieve]
-
Migeon, B. R., Luo, S., Stasiowski, B. A., Jani, M., Axelman, J., Dyke, D. L. V., Weiss, L., Jacobs, P. A., Yang-Feng, T. L., and Wiley, J. E.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
12025-12029
[Abstract/Free Full Text]
-
Brown, C. J., Lafreniere, R. G., Powers, V. E., Sebastio, G., Ballabio, A., Pettigrew, A. L., Ledbetter, D. H., Levy, E., Craig, I. W., and Willard, H. F.
(1991)
Nature
349,
82-84
[CrossRef][Medline]
[Order article via Infotrieve]
-
Devlin, R. H., Bingham, G., and Wakimoto, B. T.
(1990)
Genetics
125,
129-140
[Abstract]
-
Eberl, D. F., Duyf, B. J., and Hilliker, A. J.
(1993)
Genetics
134,
277-292
[Abstract]
-
McGhee, J. D., and Felsenfeld, G.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
2133-2137
[Abstract/Free Full Text]
-
Wang, Z., and Becker, M. M.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
654-658
[Abstract/Free Full Text]
-
Mueller, P. R., and Wold, B.
(1989)
Science
246,
780-786
[Abstract/Free Full Text]
-
Pfeifer, G. P., Steigerwald, S. D., Mueller, P. R., Wold, B., and Riggs, A. D.
(1989)
Science
246,
810-813
[Abstract/Free Full Text]
-
Javahery, R., Khachi, A., Lo, K., Zenzie-Gregory, B., and Smale, S. T.
(1994)
Mol. Cell. Biol.
14,
116-127
[Abstract/Free Full Text]
-
Pfeifer, G. P., and Riggs, A. D.
(1991)
Genes Dev.
5,
1102-1113
[Abstract/Free Full Text]
-
Hornstra, I. K., and Yang, T. P.
(1992)
Mol. Cell. Biol.
12,
5345-5354
[Abstract/Free Full Text]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Barr, A. Hermann, J. Berger, H.-H. Tsai, K. Adie, A. Prokhortchouk, B. Hendrich, and A. Bird
Mbd2 Contributes to DNA Methylation-Directed Repression of the Xist Gene
Mol. Cell. Biol.,
May 15, 2007;
27(10):
3750 - 3757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-i. Komura and T. Ono
Disappearance of Nucleosome Positioning in Mitotic Chromatin in Vivo
J. Biol. Chem.,
April 15, 2005;
280(15):
14530 - 14535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Bane, J. F. LeBlanc, T. D. Lee, and A. D. Riggs
DNA affinity capture and protein profiling by SELDI-TOF mass spectrometry: effect of DNA methylation
Nucleic Acids Res.,
July 15, 2002;
30(14):
e69 - e69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Szabó, G. P. Pfeifer, and J. R. Mann
Characterization of Novel Parent-Specific Epigenetic Modifications Upstream of the Imprinted Mouse H19 Gene
Mol. Cell. Biol.,
November 1, 1998;
18(11):
6767 - 6776.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Goto and M. Monk
Regulation of X-Chromosome Inactivation in Development in Mice and Humans
Microbiol. Mol. Biol. Rev.,
June 1, 1998;
62(2):
362 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|